PRGO IE00BGH1M568

Report

Delayed Nyse - 04:00:02 2023-03-24 pm EDT
33.85	USD		+1.62%

03/20	Health Care Up as Banking Crisis Fears Abate -- Health Care Roundup	DJ
03/20	Perrigo Recalls Baby Formula Due to Possible Contamination	DJ
03/18	Nestlé Good Start Soothe Infant Formula recalled for potential bacteria contamination	AQ

Summary

Quotes 5-day view Delayed Quote.

Delayed Nyse

03/20/2023	03/21/2023	03/22/2023	03/23/2023	03/24/2023	Date
34.95(c)	34.57(c)	33.98(c)	33.31(c)	33.85(c)	Last
1 232 005	1 886 680	1 387 304	1 107 320	832 698	Volume
+0.52%	-1.09%	-1.71%	-1.97%	+1.62%	Change

More quotes

Estimated financial data (e) (USD)

Sales 2023	4 794 M - -
Net income 2023	-17,4 M - -
Net Debt 2023	3 312 M - -
P/E ratio 2023	-260x
Yield 2023	3,23%

Sales 2024	4 983 M - -
Net income 2024	34,7 M - -
Net Debt 2024	3 041 M - -
P/E ratio 2024	135x
Yield 2024	3,55%

Capitalization	4 558 M 4 558 M -
EV / Sales 2023	1,64x
EV / Sales 2024	1,52x
Nbr of Employees	8 900
Free-Float	99,0%

More Financials

Company

Perrigo Company plc is an Ireland-based provider of over the counter (OTC) health and wellness solutions that are designed to enhance individual well-being. The Company's segments include Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises its consumer self-care business (OTC, infant formula, and oral care categories, and contract manufacturing) in the United...

Sector

Pharmaceuticals

Calendar

05/09

Earnings Release

More about the company

Ratings of Perrigo Company plc

Trading Rating :

Investor Rating :

ESG Refinitiv :

B+

More Ratings

All news about PERRIGO COMPANY PLC

03/20	Health Care Up as Banking Crisis Fears Abate -- Health Care Roundup	DJ
03/20	Perrigo Recalls Baby Formula Due to Possible Contamination	DJ
03/18	Nestlé Good Start Soothe Infant Formula recalled for potential bacteria contamination	AQ
03/15	Transcript : Perrigo Company plc Presents at UBS 12th Annual Global Consumer ..	CI
03/14	Insider Sell: Perrigo Co	MT
03/14	Insider Sell: Perrigo Co	MT
03/09	PERRIGO COMPANY PLC : Ex-dividend day for	FA
03/07	Canaccord Genuity Starts Perrigo at Buy With $49 Price Target	MT
03/07	Insider Buy: Perrigo Co	MT
03/06	Raymond James Adjusts Perrigo Price Target to $43 From $42, Maintains Outperform Rating	MT
03/02	Perrigo to Present at Upcoming 12th Annual UBS Global Consumer and Retail Conference	PR
03/01	Perrigo Obtains US FDA Approval for Tablets With Acetaminophen, Ibuprofen	MT
03/01	Perrigo Announces FDA Approval of the Store Brand OTC Equivalent of Advil® Dual Action ..	PR
03/01	Perrigo Company plc Announces FDA Approval of the Store Brand OTC Equivalent of Advil(R..	CI
02/28	Target, Perrigo rise; Norwegian, Universal Health fall	AQ

More news

News in other languages on PERRIGO COMPANY PLC

03/14	Vente d'initié : Perrigo Co
03/14	Vente d'initié : Perrigo Co
03/14	Biocorp: accord avec HRA Pharma pour développer un nouveau dispositif médical
03/14	BIOCORP : avec HRA pour un dispositif de cicatrisation
03/14	Les valeurs à suivre aujourd'hui à la Bourse de Paris - Mardi 14 mars 2023

More news

Analyst Recommendations on PERRIGO COMPANY PLC

03/07	Canaccord Genuity Starts Perrigo at Buy With $49 Price Target	MT
03/06	Raymond James Adjusts Perrigo Price Target to $43 From $42, Maintains Outperform Rating	MT
2022	Raymond James Adjusts Price Target on Perrigo Company to $42 From $48, Maintains Outper..	MT

More recommendations

Provided by Scoopnest.com

ETFs positioned on PERRIGO COMPANY PLC

ETFs and Trackers with Trackinsight

ETF	Weight	Var. 5days	Rating	Geography
Rize Medical Cannabis and Life Sciences Acc - USD	15.47%	-1.14%	-	World
AGFiQ US Market Neutral Anti-Beta Fund - USD	15.31%	0.88%		United_States
SPDR S&P Pharmaceuticals ETF - USD	4.92%	-1.23%		United_States
Invesco Dynamic Pharmaceuticals ETF - USD	3.88%	0.70%		United_States
VanEck Pharmaceutical ETF - USD	1.44%	2.17%		United_States

More ETFs positioned on PERRIGO COMPANY PLC

Analysis

Baby formula maker Perrigo buying Nestle's Good Start brand, Wisconsin plant